glp-1 back pain From Ozempic to Ouch: What's Causing That Pain? GLP-1 drugs calm inflammation beyond

FDA-approved GLP-1 medications like semaglutide and tirzepatide prescribed, dosed, and monitored personally by Dr

Semaglutide Quick Facts: Drug Class: GLP-1 receptor agonist Brand Names: Ozempic (diabetes), Wegovy (weight loss), Rybelsus (oral) FDA Approval: Ozempic approved 2017, Wegovy approved 2021 Manufacturer: Novo Nordisk Dosing: Once weekly injection, starting at 0.25 mg, maximum 2.4 mg Clinical Trial Name: STEP trials (Semaglutide Treatment Effect in People with obesity) Average Weight Loss: 10-15% of body weight over 68 weeks Tirzepatide Quick Facts: Drug Class: Dual GIP/GLP-1 receptor agonist Brand Names: Mounjaro (diabetes), Zepbound (weight loss) FDA Approval: Mounjaro approved 2022, Zepbound approved 2023 Manufacturer: Eli Lilly Dosing: Once weekly injection, starting at 2.5 mg, maximum 15 mg Clinical Trial Name: SURMOUNT trials (Study to evaluate tirzepatide in obesity or overweight) Average Weight Loss: 15-22% of body weight over 72 weeks Primary Difference: The main distinction is that semaglutide activates only GLP-1 receptors, while tirzepatide activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors

Inference of macromolecular assemblies from crystalline state

Matt Williams: Sure

She also recommends small, nutrient-dense meals, such as eggs with berries or avocado toast on a rice cake with smoked salmon

Key takeaways Mounjaro is a GLP-1 medication that also acts on GIP receptors to regulate blood sugar levels